EuroIntervention PCRonline - Connecting with the community
Launch me!

Scot Garg

26 articles

The FIREHAWK® stent: will it achieve its potential?

EuroIntervention 2013;9:15-20

Published in Volume 9 Number 1, May 2013

Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe

EuroIntervention 2011;7:859-871

Published in Volume 7 Number 7, November 2011

How should I treat impaired systolic function and clinical deterioration after surgery of type A aortic dissection?

EuroIntervention 2011;7:638-646

Published in Volume 7 Number 5, September 2011

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial

EuroIntervention 2011;7:605-613 publish online ahead of print June 2011

Published in Volume 7 Number 5, September 2011

Moxy® drug-coated balloon: a novel device for the treatment of coronary and peripheral vascular disease

EuroIntervention 2011;7:274-277 published online ahead of print May 2011

Published in Volume 7 Number 2, June 2011

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

EuroIntervention 2011;6:1110-1116

Published in Volume 6 Number 9, April 2011

Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study

EuroIntervention 2011;6:1060-1067

Published in Volume 6 Number 9, April 2011

Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study

EuroIntervention 2011;6:977-984

Published in Volume 6 Number 8, March 2011

The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer

EuroIntervention 2011;6:928-935

Published in Volume 6 Number 8, March 2011

Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)

EuroIntervention 2011;5:838-845

Published in Volume 6 Number 7, February 2011

The coronary Stent-On-A-Wire (SOAW)

EuroIntervention 2010;6:413-417

Published in Volume 6 Number 3, August 2010

A comparison of the distribution of necrotic core in bifurcation and non-bifurcation coronary lesions: an in vivo assessment using intravascular ultrasound radiofrequency data analysis

EuroIntervention 2010;6:321-327

Published in Volume 6 Number 3, August 2010

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer

EuroIntervention 2010;6:233-239

Published in Volume 6 Number 2, June 2010

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study

EuroIntervention 2010;6:195-205

Published in Volume 6 Number 2, June 2010

How should I treat a tortuous calcified right coronary artery?

EuroIntervention 2010;6:161-167

Published in Volume 6 Number 1, May 2010

The coronary stent-on-a-wire (SOAW)

Published in Volume 6 Supplement H, May 2010

Conformability of bioresorbable Everolimus-eluting scaffolds as compared to metal platform stents

Published in Volume 6 Supplement H, May 2010

Multicentre, prospective, randomised, single blind, consecutive enrollment evaluation of the Elixir Novolimus-eluting coronary stent system with durable polymer compared to the Endeavor Zotarolimus-eluting coronary stent system: 12-month clinical results and 9-month angiographic and IVUS results - the Excella II study

Published in Volume 6 Supplement H, May 2010

In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial

EuroIntervention 2010;5:932-938

Published in Volume 5 Number 8, April 2010

First use in patients of a combined near infra-red spectroscopy and intra-vascular ultrasound catheter to identify composition and structure of coronary plaque

EuroIntervention 2010;5:755-756

Published in Volume 5 Number 6, January 2010

Ten-year follow-up of the IGAKI-TAMAI stent.

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F109-F111

Published in Volume 5 Supplement F, December 2009

How should I treat a complex Post-CABG patient?

EuroIntervention 2009;5:627-632

Published in Volume 5 Number 5, November 2009

The outcome of bifurcation lesion stenting using a biolimus eluting stent with a biodegradable polymer compared to a sirolimus eluting stent with a durable polymer

Published in Volume 5 Supplement E, May 2009

Five-year clinical outcomes of the arterial revascularisation therapies (ARTS-II) study of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions

Published in Volume 5 Supplement E, May 2009

Assessment of the SYNTAX score in the Syntax study

EuroIntervention 2009;5:50-56

Published in Volume 5 Number 1, May 2009

Meditations on secondary revascularisation in the aftermath of the SYNTAX trial

EuroIntervention Supplement (2009) Vol. 5 (Supplement D) D14-D20

Published in Volume 5 Supplement D, May 2009